Oppenheimer Asset Management Inc. reduced its position in Agilent Technologies, Inc. (NYSE:A) by 24.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,435 shares of the medical research company’s stock after selling 7,415 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Agilent Technologies were worth $1,390,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently added to or reduced their stakes in the company. Parallel Advisors LLC raised its holdings in Agilent Technologies by 5.3% in the 2nd quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock worth $157,000 after purchasing an additional 131 shares during the period. Trust Co. of Vermont raised its holdings in Agilent Technologies by 1.8% in the 2nd quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock worth $166,000 after purchasing an additional 50 shares during the period. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC raised its holdings in Agilent Technologies by 17.2% in the 2nd quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC now owns 3,319 shares of the medical research company’s stock worth $196,000 after purchasing an additional 486 shares during the period. Teacher Retirement System of Texas bought a new position in Agilent Technologies in the 2nd quarter worth $200,000. Finally, ELM Advisors LLC bought a new position in Agilent Technologies in the 2nd quarter worth $202,000.
In other Agilent Technologies news, insider Patrick Kaltenbach sold 5,000 shares of the stock in a transaction on Thursday, July 13th. The shares were sold at an average price of $61.26, for a total transaction of $306,300.00. Following the sale, the insider now directly owns 45,138 shares of the company’s stock, valued at $2,765,153.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Didier Hirsch sold 1,200 shares of the stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $66.00, for a total transaction of $79,200.00. Following the sale, the chief financial officer now directly owns 164,202 shares in the company, valued at $10,837,332. The disclosure for this sale can be found here. Insiders sold 155,165 shares of company stock valued at $9,768,409 over the last 90 days.
A number of equities research analysts have commented on A shares. Deutsche Bank AG reissued a “buy” rating and set a $66.00 price target on shares of Agilent Technologies in a report on Thursday, June 22nd. Morgan Stanley lifted their target price on Agilent Technologies from $65.00 to $70.00 and gave the stock an “overweight” rating in a report on Wednesday, May 24th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $66.00 target price on shares of Agilent Technologies in a report on Wednesday, August 9th. BTIG Research lifted their target price on Agilent Technologies from $57.00 to $65.00 and gave the stock a “buy” rating in a report on Wednesday, May 24th. Finally, BidaskClub cut Agilent Technologies from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 13th. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $63.91.
Shares of Agilent Technologies, Inc. (NYSE:A) traded up 0.43% on Friday, hitting $65.96. The company’s stock had a trading volume of 2,295,974 shares. The stock has a 50-day moving average price of $62.40 and a 200 day moving average price of $58.01. Agilent Technologies, Inc. has a one year low of $42.92 and a one year high of $66.42. The firm has a market cap of $21.23 billion, a price-to-earnings ratio of 34.02 and a beta of 1.30.
Agilent Technologies (NYSE:A) last announced its earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.07. The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.49 earnings per share. Equities research analysts predict that Agilent Technologies, Inc. will post $2.32 EPS for the current year.
COPYRIGHT VIOLATION WARNING: “Agilent Technologies, Inc. (A) Shares Sold by Oppenheimer Asset Management Inc.” was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this news story on another site, it was illegally copied and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this news story can be read at https://stocknewstimes.com/2017/09/16/agilent-technologies-inc-a-position-cut-by-oppenheimer-asset-management-inc.html.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.